NGM BIOPHARMACEUTICALS CEO David Woodhouse's 2020 pay jumps 118% to $4.6M
NGM BIOPHARMACEUTICALS reports 2020 executive compensation
By ExecPay News
Published: April 28, 2021
NGM BIOPHARMACEUTICALS reported fiscal year 2020 executive compensation information on April 28, 2021.
In 2020, four executives at NGM BIOPHARMACEUTICALS received on average a compensation package of $2.9M, a 64% increase compared to previous year.
Average pay of disclosed executives at NGM BIOPHARMACEUTICALS
David J. Woodhouse, Chief Executive Officer, received $4.6M in total, which increased by 118% compared to 2019. 84% of Woodhouse's compensation, or $3.8M, was in option awards. Woodhouse also received $200K in bonus, $525K in salary, as well as $750 in other compensation.
Siobhan Nolan Mangini, Chief Financial Officer, received a compensation package of $3.8M. 91% of the compensation package, or $3.5M, was in option awards.
Jin-Long Chen, Chief Scientific Officer, earned $2.4M in 2020, a 23% increase compared to previous year.
Hsiao D. Lieu, Chief Medical Officer, received $822K in 2020.
Related executives
You may also like
Source: SEC filing on April 28, 2021.